Funded Tech Companies
Excelsior Sciences
Excelsior Sciences is a biopharmaceutical tech company, based in New York. Venture investment and financing was provided by Eli Lilly and Company, IllinoisVENTURES and MIT Investment Management Company.
Company Overview
Company Name
Excelsior Sciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Excelsior Sciences is leveraging a new form of chemistry that machines can do, AI can learn from, and anyone can engage. With our smart blocc platform, we're ending chemistry's 200-year artisanal phase and ushering in its automated era, reducing cost and complexity while making molecular solutions accessible across industries. We are developing our own proprietary therapeutic pipeline while also collaborating with partners across industries where small molecules are key -- including pharmaceuticals, materials science, and agtech. By combining proprietary chemistry with a closed-loop discovery and manufacturing platform, we enable the creation of superior small-molecule solutions and unlock new possibilities for innovation across these sectors.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/4/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Foley
Company Investors
- Eli Lilly and Company
- IllinoisVENTURES
- MIT Investment Management Company
- Cornucopian Capital
- Sofinnova Partners
- Khosla Ventures
- Deerfield Management Company
- Empire State Development
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs